« Return to News | Drug Sponsors

AAHRPP Accredits Another 13

Thursday, June 18, 2009 06:57 AM

The Association for the Accreditation of Human Research Protection Programs (AAHRPP) accredited another 13 organizations last week, bringing the total number of AAHRPP-accredited organizations to 188.

AAHRPP, a non-profit organization that offers accreditation to organizations that conduct or review research with humans, hopes to accredit the majority of academic health centers by 2010. Earlier this year, Pfizer became the first pharma company to achieve accreditation.

The list of organizations that received full accreditation includes: Beth Israel Deaconess Medical Center, Boston, Mass.; G.V. (Sonny) Montgomery VAMC, Jackson, Miss.; Louisiana State University Health Sciences Center--Shreveport, Shreveport, La.; Nationwide Children's Hospital, Columbus, Ohio; Overton Brooks VA Medical Center, Shreveport, La.; South Texas Veterans Health Care System, San Antonio, Texas; Southeast Louisiana Veterans Healthcare System, New Orleans, La.; Syracuse VA Medical Center, Syracuse, N.Y.; The University of Colorado Denver, Denver, Colo.; The University of Texas Health Science Center at Houston, Houston, Texas; The University of Texas Health Science Center at San Antonio, San Antonio, Texas; University of California, Los Angeles, Los Angeles, Calif.; and VA Eastern Colorado Health Care System, Denver, Colo.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.